These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1150 related items for PubMed ID: 8672521

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA, Theodore J.
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [Abstract] [Full Text] [Related]

  • 3. Obstructive flow-volume loop contours after single lung transplantation.
    Ross DJ, Belman MJ, Mohsenifar Z, Nathan SD, Kass RM, Koerner SK.
    J Heart Lung Transplant; 1994 Apr; 13(3):508-13. PubMed ID: 8061028
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies.
    Starnes VA, Theodore J, Oyer PE, Billingham ME, Sibley RK, Berry G, Shumway NE, Stinson EB.
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 1):683-90. PubMed ID: 2554067
    [Abstract] [Full Text] [Related]

  • 5. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome.
    Kesten S, Chaparro C, Scavuzzo M, Gutierrez C.
    J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139
    [Abstract] [Full Text] [Related]

  • 6. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ, Marchevsky A, Kramer M, Kass RM.
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [Abstract] [Full Text] [Related]

  • 7. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Hohlfeld J, Niedermeyer J, Hamm H, Schäfers HJ, Wagner TO, Fabel H.
    J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M, Maurer J, Winton T, Kesten S.
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [Abstract] [Full Text] [Related]

  • 11. [Volumetric correction of the maximal expiratory flow 25-75% in chronic obstructive bronchopneumopathies].
    Dull WL, Alexander MR, Kasik JE.
    Rev Fr Mal Respir; 1982 Sep; 10(5):337-44. PubMed ID: 7178638
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
    Reichenspurner H, Girgis RE, Robbins RC, Yun KL, Nitschke M, Berry GJ, Morris RE, Theodore J, Reitz BA.
    Ann Thorac Surg; 1996 Nov; 62(5):1467-72; discussion 1472-3. PubMed ID: 8893585
    [Abstract] [Full Text] [Related]

  • 14. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.
    Shitrit D, Amital A, Fox B, Kramer MR.
    Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T.
    J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 58.